Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Maria Zannes

Maria Zannes is recorded as CEO and Board Member at bioAffinity Technologies, Inc. (BIAF). bioAffinity Technologies, Inc. reported in an 8-K filed June 5, 2024 that Maria Zannes was appointed Director, effective June 4, 2024. bioAffinity Technologies, Inc. reported in an 8-K filed June 7, 2023 that Maria Zannes was appointed director, effective June 6, 2023. The proxy statement of bioAffinity Technologies, Inc. reports total compensation of $434,983 for Maria Zannes in fiscal 2025, including a base salary of $330,000. Disclosed compensation is on record for 5 fiscal years.

“The stockholders elected each of the eight director nominees to serve on the Board until the 2025 Annual Meeting of Stockholders and until such director's successor has been duly elected and qualified.”
bioAffinity Technologies, Inc. Form 8-K, filed June 5, 2024 · Read the filing
“The stockholders elected each of the seven director nominees to serve on the Board until the 2024 Annual Meeting of Stockholders and until such director's successor has been duly elected and qualified.”
bioAffinity Technologies, Inc. Form 8-K, filed June 7, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at bioAffinity Technologies, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 bioAffinity Technologies, Inc. (BIAF) $330,000 $434,983
2024 bioAffinity Technologies, Inc. (BIAF) $291,666 $477,155
2023 bioAffinity Technologies, Inc. (BIAF) $261,671 $424,168
2022 bioAffinity Technologies, Inc. (BIAF) $253,343 $351,287
2021 bioAffinity Technologies, Inc. (BIAF) $220,005 $264,404

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.